No Data
No Data
Express News | Kenneth Griffin Reports 5.3% Passive Stake In Terns Pharmaceuticals As Of July 10
Express News | Kenneth Griffin Reports 5.3% Passive Stake in Terns Pharmaceuticals as of July 10 - SEC Filing
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Form 144 | Terns Pharmaceuticals(TERN.US) Director Proposes to Sell 9.09 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 15, $Terns Pharmaceuticals(TERN.US)$ Director OrbiMed Private Investments VII, LP intends to sell 976.8K shares of its common stock on Jul 15, with a total market value
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
Mizuho Securities Keeps Their Buy Rating on Terns Pharmaceuticals (TERN)